A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease (MONET) (Substudy B)
Substudy B Final Analysis: A Phase 3 Protocol to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Adults at High Risk of Severe RSV Disease
Category & Conditions: Vaccine-related Conditions
Medicine: PF-06928316
ClinicalTrials.gov Identifier (NCT): NCT05842967
Protocol ID: C3671023 (Substudy B)
Open Plain Language Summary Result:
Click here